The construction of 585 Kendall, a mixed-use development in Kendall Square, Massachusetts, US, has reached a milestone with its topping-off ceremony.
The event celebrated the efforts of the construction teams from Suffolk, a real estate and construction enterprise, in achieving this stage of the project.
The 585 Kendall development, designed by CBT Architects, is a combination of lab and office space and a performing arts centre.
The 16-storey building, developed and owned by BioMed Realty, a real estate solutions provider, aims to become a key quarter within the Canal District, maintaining the neighbourhood’s hub reputation.
Set for occupancy in 2026, 585 Kendall is claimed to be designed to cater to the diverse needs of the Cambridge community.
The building will feature a 30,000ft² performing arts centre, including a 400-seat performance space, multipurpose rooms, and an indoor garden developed in partnership with Global Arts Live.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThis space will provide artists and community members with areas for rehearsal, performance, and gatherings.
The building aims to secure Leadership in Energy and Environmental Design Gold certification or higher, along with other green building certifications.
It will also offer water and energy efficiency, powered by 100% renewable electricity to minimise greenhouse gas emissions.
Enhanced ventilation, the avoidance of harmful chemicals such as volatile organic compounds, and the application of biophilic design principles, meanwhile, are claimed to improve the well-being of occupants.
Suffolk chair and CEO John Fish said: “We are honoured and privileged to celebrate this important milestone in the construction of this complex facility.
“Building a sophisticated project in the heart of the innovation district of Cambridge requires vision, dedication, innovation and collaboration. Thank you to BioMed and Takeda for their close partnership, for their investment in this community, and for their faith in Suffolk to deliver this game-changing project for the life sciences community, the City of Cambridge and the Commonwealth of Massachusetts.”
